Claritev Corporation, a healthcare technology, data, and insights company, has announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. This investment will fund the launch of a co-branded Payment Acceleration Service, which will be integrated within Claritev’s extensive provider network, aiming to provide healthcare organizations faster and more predictable access to reimbursements across the U.
S. and MENA regions.
The collaboration supports Claritev’s expansion in the MENA region and Klaim’s growth across the U.
S. The Claritev–Klaim Payment Acceleration platform is designed to allow eligible healthcare providers to convert pending insurance claims into near-instant liquidity, aiming to reduce the typical 30–120-day reimbursement cycle for medical claims. This initiative combines Claritev’s payor-provider infrastructure and its ACE analytics platform with Klaim’s payment-acceleration technology.
As part of the partnership, Klaim will leverage Claritev’s Advanced Code Editing (ACE) technology for claim coding intelligence. This technology will be used to evaluate claims qualified for funding, enhancing the efficiency and accuracy of the acceleration process. The anticipated benefits for participating providers include certainty of payment for qualifying claims, reduced risk of cash flow gaps from denials or delays, flexible usage based on working capital needs, reduced administrative burden through Klaim’s handling of reconciliation and payor follow-up, and scalable access for various sizes of healthcare operations.
Will Mintz, Chief Strategy Officer at Claritev, stated, “Our investment in Klaim reflects Claritev’s commitment to modernizing provider cash flow and strengthening financial resilience across the healthcare system. By combining Claritev’s trusted provider relationships and ACE technology with Klaim’s fintech infrastructure, we’re helping providers get paid faster and operate with greater confidence.”
Karim Dakki, Co-Founder & CEO of Klaim, added, “This relationship is about unlocking liquidity at scale for healthcare providers. Together with Claritev, we’re bringing a data-driven solution that turns delayed reimbursements into predictable cash flow, helping practices stay focused on delivering care rather than chasing payments.” He also noted that the investment marks the beginning of Klaim’s global restructuring, which is anticipated to unify Klaim Middle East (under Klaim Holdings Limited) and Klaim, Inc. under a planned global holding company.
Claritev is a healthcare technology, data, and insights company focused on improving affordability, transparency, and quality in healthcare. With over 40 years of claims repricing experience, Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers, utilizing AI solutions to power its enterprise platform.
Klaim, Inc., founded by Karim Dakki and Ghafoor Ahmad, is a healthcare-fintech company that enables healthcare providers to accelerate insurance reimbursements and improve cash flow predictability. Its proprietary AI-powered funding technology can convert pending claims into cash within 24 hours.
